Lale White, executive chairman and CEO, XIFIN Economic pressures, legislative mandates, and technological advancements are driving significant changes in the diagnostic services segment, while reimbursement for lab testing and diagnost
Read More
Changing the role of informatics in personalized medicine
Read MoreA mutant protein found in nearly all pancreatic cancers plays a role not only in the cancer’s development but in its continued growth.
Read MorebioTheranostics Inc introduces a new product line of high medical value biomarkers for response, resistance, and pathway interrogation called PRECIS Precision Medicine.
Read MoreQIAGEN has come to agreements with two US biotech companies to acquire worldwide exclusive rights to biomarkers that are expected to play an important role in personalized treatment of various cancers.
Read More